Previous 10 | Next 10 |
home / stock / cphrf / cphrf news
Cipher Pharmaceuticals ( OTC:CPHRF ): Q3 GAAP EPS of -$0.08 misses by $0.12 . More news on: Cipher Pharmaceuticals Inc., Earnings news and commentary, , Read more ...
Cipher Pharmaceuticals Reports Third Quarter 2019 Financial Results Canada NewsWire OAKVILLE, ON, Nov. 7, 2019 Revenue increased 20% to $5.8 million OAKVILLE, ON , Nov. 7, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announc...
Notice of Cipher Pharmaceuticals Q3 2019 Conference Call Canada NewsWire OAKVILLE, ON, Oct. 24, 2019 OAKVILLE, ON , Oct. 24, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced the details of its Q3 2019 financial results confer...
Cipher Pharmaceuticals Receives Health Canada Approval For Trulance® (Plecanatide) Canada NewsWire OAKVILLE, ON, Oct. 18, 2019 OAKVILLE, ON , Oct. 18, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced it has received Heal...
With one product candidate at Phase 3 of development and expecting completion in early 2020, Aclaris Therapeutics ( ACRS ) is a name to be followed carefully. The Phase 3 trial is estimated to be completed on January 15, 2020. With that said, the company’s cash burn rate is very signifi...
Cipher Pharmaceuticals Inc. (OTC:CPHRF) Q2 2019 Earnings Conference Call August 9, 2019 8:30 AM ET Company Participants Craig Mull - Interim Chief Executive Officer Nadine Jutlah - Interim Chief Financial Officer Conference Call Participants Andre Uddin - Mackie Research ...
Cipher Pharmaceuticals ( OTC:CPHRF ): Q2 GAAP EPS of $0.05 beats by $0.01 . More news on: Cipher Pharmaceuticals Inc., Earnings news and commentary, , Read more ...
Cipher Pharmaceuticals Reports Second Quarter 2019 Financial Results Canada NewsWire MISSISSAUGA, ON, Aug. 9, 2019 Company also provides update on strategic priorities MISSISSAUGA, ON, Aug. 9, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or...
Notice of Cipher Pharmaceuticals Q2 2019 Conference Call Canada NewsWire OAKVILLE, ON, July 30, 2019 OAKVILLE, ON , July 30, 2019 /CNW/ - Cipher Pharmaceuticals Inc. (TSX:CPH) ("Cipher" or "the Company") today announced the details of its Q2 2019 financial results ...
Cipher Pharmaceuticals Announces Management Change & Preliminary Q2 Financial Highlights Cipher Pharmaceuticals Announces Management Change & Preliminary Q2 Financial Highlights Canada NewsWire MISSISSAUGA, ON, July 29, 2019 Company also forms Special Committee ...
News, Short Squeeze, Breakout and More Instantly...
Companhia Siderurgica Paulista Nova Cosipa Company Name:
CPHRF Stock Symbol:
OTCMKTS Market:
Companhia Siderurgica Paulista Nova Cosipa Website:
Cipher Pharmaceuticals Announces Results of Annual and Special Meeting of Shareholders Canada NewsWire MISSISSAUGA, ON , June 14, 2024 /CNW/ - Cipher Pharmaceuticals Inc . (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the "Company ") today announced that i...
Cipher Pharmaceuticals Reports First Quarter 2024 Results Canada NewsWire (All figures are presented in U.S. Dollars) Adjusted EBITDA in Q1 2024 was $3.6 million , an increase of 12.5% over Q1 2023 Epuris sales volumes grew 7.2% in the quarter over Q1 2023, c...
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call Canada NewsWire MISSISSAUGA, ON , May 3, 2024 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release ...